Critical Path Public Private Partnerships Clinical Trials Optional
Last verified by NonDilute: 2026-04-29. Official notice and agency instructions control.
FDA-backed clinical trial funding for companies and institutions willing to collaborate in public-private partnerships, but applicants must navigate an opaque, low-information listing.
Report stale or inaccurate summary
What this is
The Critical Path Public Private Partnerships Clinical Trials program is an FDA-backed initiative to advance clinical research through collaborative public-private models. However, this listing provides minimal detail: no budget range, no explicit eligibility criteria, no formal description, and an unknown close date. Interested applicants would need to contact FDA directly or consult the full CFDA 93.103 program guidance to determine fit, funding levels, and submission requirements.
Who can apply
Eligibility is unspecified in this posting. Applicants should assume organizations conducting FDA-regulated clinical trials in partnership models may qualify, but must consult CFDA 93.103 guidance or contact FDA directly for definitive criteria on organizational type, size, and geography.
Topics: fda clinical trials · public private partnership · critical path · drug development · clinical research funding
Public-source funding discovery only. This summary is generated from public agency data and may be incomplete or stale. NonDilute is not affiliated with, endorsed by, or acting on behalf of any government agency. Official notices and agency instructions control. NonDilute does not determine eligibility, provide grant-writing advice, or guarantee funding.